OnKure (OKUR): Biji pasar

The market trend for OnKure Therapeutics Inc (OKUR) demonstrates a capitalization of 0.09. The business is building a precision oncology network by implementing advanced HDAC inhibitors to combat tumor resistance. Environmental impact is minimal, limited only to the strict control of laboratory waste. The patents for the OKI-179 molecule are particularly valuable, as it specifically targets breast cancer mutations, providing the company with immense pricing power.

OKUR OnKure Therapeutics: Nilai pasar ing interval 08.10.2024 - 22.10.2026

Rincian metrik lan analitis perusahaan onkuretherapeutics.com (OKUR)

OnKure Therapeutics (OKUR): dhaptar indikator lan metrik:

Bagan rega OnKure Therapeutics|OKUR - Prakiraan konsensus analis|Biji pasar OKUR

Pambiji fundamental perusahaan:OnKure OKUR

Sampel barang OnKure Therapeutics

Investing in OnKure Therapeutics Inc (OKUR) requires a strict fundamental approach to valuation. Market capitalization is determined by the product of the current share price and the total number of outstanding securities. By analyzing the issuer's aggregate capitalization, an investor separates market noise from real business dynamics. This indicator reflects the market value of the company's exclusive patent rights and FDA protocols. High technological barriers make this capital resilient to competition.

Pesaing OnKure Therapeutics Inc (OKUR)

Nilai pasar BeiGene ONC|Kapitalisasi pasar Halozyme Therapeutics, Inc. HALO|RVMD: Biji pasar|AAPG - Kapitalisasi pasar|CG Oncology, Inc. (CGON) - Nilai pasar|urogen.com - Nilai pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Nilai pasar Adlai Nortye Ltd. (ANL)|VERU - Nilai pasar|Nilai pasar Tempest Therapeutics, Inc. TPST|XLO: Kapitalisasi pasar|RENB - Nilai pasar|MURA - Kapitalisasi pasar|KAPA (kairospharma.com) - Biji pasar|CytoMed Therapeutics Limited (GDTC) - Kapitalisasi pasar|Nilai pasar Curis Inc.|APLM: Nilai pasar|Kapitalisasi pasar THAR|ADVB - Nilai pasar|Genprex, Inc. - Biji pasar|Nilai pasar CLDI|SBFM: Biji pasar|Xenetic Biosciences - Nilai pasar|SLRX: Kapitalisasi pasar|Kitov Pharma - Nilai pasar|AONC (American Oncology Network Inc) - Kapitalisasi pasar|Nilai pasar beigene.com BGNE|Nilai pasar Checkpoint Therapeutics, Inc. (CKPT)|ELEV (Elevation Oncology Inc.) - Nilai pasar|Kapitalisasi pasar ICAD (iCAD)|Kapitalisasi pasar Ikena Oncology Inc. IKNA|NTBL - Nilai pasar|Biji pasar VIRX|MOR: Kapitalisasi pasar|Nilai pasar NAYA Biosciences Inc (NAYA)|Biji pasar AAPGV